Waring W Stephen
Clinical Pharmacology Unit, The University of Edinburgh, Western General Hospital, Crewe Road, EH4 2XU Edinburgh, Scotland, UK.
Eur J Clin Pharmacol. 2003 Sep;59(5-6):351-6. doi: 10.1007/s00228-003-0632-0. Epub 2003 Jul 25.
Tobacco use represents the single most important preventable health hazard world-wide. Its consumption confers substantially increased mortality and morbidity due to cardiovascular, cerebrovascular and respiratory disease, and malignancy in a number of sites. A key goal towards improving public health in developing and developed countries alike is to reduce tobacco use across populations. Despite this, current data suggest that global tobacco use is increasing. There have been recent pharmacological advances that offer the hope of achieving more effective tobacco cessation and reduced consumption among established tobacco users. These are discussed in further detail, with reference to evidence supporting their use in clinical practice.
吸烟是全球最重要的可预防健康危害因素。吸烟会大幅增加因心血管、脑血管和呼吸系统疾病以及多处恶性肿瘤导致的死亡率和发病率。在发展中国家和发达国家,改善公众健康的一个关键目标都是减少全体人群的吸烟行为。尽管如此,目前的数据表明全球吸烟率仍在上升。最近在药理学方面取得了进展,有望在现有吸烟者中实现更有效的戒烟并减少吸烟量。本文将结合支持其在临床实践中应用的证据,对这些进展进行更详细的讨论。